The global market for legal marijuana is valued at $17.7 billion as of 2019, and Grand View Research says that number is expected to rise to $73.6 billion by 2027. A quickly evolving market, more interim and project-based executives are being called on to lead the charge.
Jon Paul started his career at Arthur Anderson in the seventies then moved to multiple Chief Financial Officer positions, before getting on the cannabis bus in 2018 when he was recruited to take San Francisco-based gummies company, Plus Products, public.
Cannabis industry newsletter Grown In interviewed Jon Paul about the challenges involved in taking a company to a listing on the Canadian Stock Exchange.
The best, truest, and most bleak line I’ve heard from a mega-successful company founder was Dave Becker telling me: “we have all had the sleepless nights, when it’s 2am and you’re staring at the ceiling.” Dave is the founder of a number of companies including First Internet Bancorp (Nasdaq: INBK), the granddaddy of online banking.
From the outside, we see a successful entrepreneur with multiple home runs and think they must be sitting on easy street. What could possibly go wrong?
The answer is: everything. It always appears easy or obvious once a company has made it, but what we often don’t hear about are the trials and tribulations that happen at every stage of a company’s growth from young and unknown, to in between, and then big and ambitious. The sleepless nights. The questions of can you make payroll. The we-almost-went-bankrupt moments. This is real and it’s no surprise that many of our inquiries for help from owners show up in our inbox after the 9-5 employees have gone home.
Everyone knows the U.S. healthcare delivery system is sick, and cost increases unsustainable. Difficult reforms are underway, piecemeal and painful.
Many experts have taken a swing at the U.S. healthcare behemoth. Who is powerful enough to take the problem on? Probably not government, probably not hospital groups, and probably not insurance companies, according to Ron Hammerle, an interim executive specializing in the healthcare field.
The solution to healthcare, Hammerle argues, involves large U.S. retailers, including those who might run the local supermarket. Still a minority viewpoint at this point, but Hammerle said it is rapidly catching on.
A manufacturing renewal is quietly developing in the United States. The US is re-emerging as a best value manufacturing nation and is now very competitive with low labor cost countries.
Verto Partners LLC, a performance improvement firm serving the middle market as advisors to management, as interim management or in Board of Directors roles, has been tracking this “re-birth” and compiling information regarding emerging trends that currently support and will enable US manufacturing growth to accelerate in the coming decade. Any Company considering its own plans for manufacturing and/or sourcing manufactured components outside of the US should reconsider those plans in light of this developing trend. Furthermore, any non-US company considering manufacturing for the American market should consider investing in the United States.
(This article was co-written with Lance Wimmer.)
Yes — Contact Me Now to Initiate a Search
Association Membership Application
First-year Change Agent members have access to the Interim Institute’s 4 hour audio program on the Fundamentals of Interim Management, and a one-hour strategy session to help jumpstart their interim career.
*$200 additional charge for Accelerator Program only applies for first-year members. After the first year, membership renews at $485/year.